SIGNALOMICS GMBH has a total of 30 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHUNG BONG HYUN, CYCLOLAB CIKLODEXTRIN KUTATO F and PROLUME LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 4 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Hong Kong | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Australia | 1 | |
#9 | Brazil | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 | |
#12 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Micro-structure and nano-technology | |
#5 | Machines | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Block Christoph | 23 |
#2 | Arntz Claudia | 20 |
#3 | Mittmann Karin | 17 |
#4 | Zeller Kathrin | 7 |
#5 | Laarmann Sven | 6 |
#6 | Meinders Danielle | 5 |
#7 | Janknecht Ralf | 3 |
#8 | Arntz Claudia Dr | 3 |
#9 | Block Christoph Dr | 3 |
#10 | Sven Laarmann S | 1 |
Publication | Filing date | Title |
---|---|---|
BRPI0822328A2 | Optimized adhesin fragments and corresponding nanoparticles | |
WO2008074461A2 | Fluorescent nanoparticles | |
WO2007068478A1 | Rna helicase as marker for rare tumours | |
EP2308513A2 | Fluorescent nanoparticles | |
EP1777292A1 | Method for the generation of genetic diversity in vivo | |
EP1721974A1 | Competitive n-hybrid system | |
EP1561809A2 | Eucaryotic cell expressing phycocyanin |